Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Hettema

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Netherlands Journal of Medicine|April 6, 1999
Beer drinker's hyponatraemia: a case reportM E Hettema, C Halma
Rheumatology (Oxford, England)|March 7, 2008
Macrovascular disease and atherosclerosis in SScM E Hettema, H Bootsma, C G M Kallenberg
Annals of the Rheumatic Diseases|September 21, 2007
Bosentan therapy for patients with severe Raynaud's phenomenon in systemic sclerosisM E Hettema, D Zhang, H Bootsma, et al.
Clinical Rheumatology|April 21, 2017
The added value of synovial fluid centrifugation for monosodium urate and calcium pyrophosphate crystal detectionD Boumans, M E Hettema, H E Vonkeman, et al.
International Journal of Rheumatology|October 7, 2011
Skin autofluorescence, as marker of accumulation of advanced glycation endproducts and of cumulative metabolic stress, is not increased in patients with systemic sclerosisM E Hettema, H Bootsma, R Graaff, et al.
Rheumatology (Oxford, England)|July 17, 2008
Decreased capillary permeability and capillary density in patients with systemic sclerosis using large-window sodium fluorescein videodensitometry of the ankleM E Hettema, D Zhang, Y Stienstra, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Netherlands Journal of Medicine|April 6, 1999
Beer drinker's hyponatraemia: a case reportM E Hettema, C Halma
Rheumatology (Oxford, England)|March 7, 2008
Macrovascular disease and atherosclerosis in SScM E Hettema, H Bootsma, C G M Kallenberg
Annals of the Rheumatic Diseases|September 21, 2007
Bosentan therapy for patients with severe Raynaud's phenomenon in systemic sclerosisM E Hettema, D Zhang, H Bootsma, et al.
Clinical Rheumatology|April 21, 2017
The added value of synovial fluid centrifugation for monosodium urate and calcium pyrophosphate crystal detectionD Boumans, M E Hettema, H E Vonkeman, et al.
International Journal of Rheumatology|October 7, 2011
Skin autofluorescence, as marker of accumulation of advanced glycation endproducts and of cumulative metabolic stress, is not increased in patients with systemic sclerosisM E Hettema, H Bootsma, R Graaff, et al.
Rheumatology (Oxford, England)|July 17, 2008
Decreased capillary permeability and capillary density in patients with systemic sclerosis using large-window sodium fluorescein videodensitometry of the ankleM E Hettema, D Zhang, Y Stienstra, et al.
Pageof 1